Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML (OPAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00780598
Recruitment Status : Completed
First Posted : October 27, 2008
Last Update Posted : June 28, 2012
Quintiles, Inc.
Information provided by (Responsible Party):
Chroma Therapeutics